Approval · Notice of Compliance 23888 · 2020
XENLETA: Notice of Compliance 23888
Issued July 10, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 23888
- Date
- July 10, 2020
- Company
- Sunovion Pharmaceuticals Canada IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority-NAS
Products in this notice
Medicinal ingredients
- LEFAMULIN ACETATE 10 MG per ML
- LEFAMULIN ACETATE 600 MG per TAB